Alireza Homayouni

Alireza Homayouni

Auto-generated profile, based on publicly available information

Alireza Homayouni


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
FSFatemeh Sadeghi
Fatemeh Sadeghi
MAMohammad Ashofteh
Mohammad Ashofteh
AHAlireza Homayouni
Alireza Homayouni
MAMohammadreza Abbaspour
Mohammadreza Abbaspour
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi
HGHadi Afrasiabi Garekani
Hadi Afrasiabi Garekani

1 September 2014 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
AHAlireza Homayouni
Alireza Homayouni
FSFatemeh Sadeghi
Fatemeh Sadeghi
JVJaleh Varshosaz
Jaleh Varshosaz
HGHadi Afrasiabi Garekani
Hadi Afrasiabi Garekani
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi

1 October 2014 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
AHAlireza Homayouni
Alireza Homayouni
FSFatemeh Sadeghi
Fatemeh Sadeghi
JVJaleh Varshosaz
Jaleh Varshosaz
HGHadi Afrasiabi Garekani
Hadi Afrasiabi Garekani
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi

1 March 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
RGRoya Ghanavati
Roya Ghanavati
ATazade taheri
azade taheri
AHAlireza Homayouni
Alireza Homayouni

18 May 2015 in RSC Advances
Verified
Journal Article
Open access
PDF file
Ali NokhodchiAli Nokhodchi
Ali Nokhodchi
AHAlireza Homayouni
Alireza Homayouni
RARuta Araya
Ruta Araya
WKWaseem Kaialy
Waseem Kaialy
WOWasfy Obeidat
Wasfy Obeidat
Kofi Asare-AddoKofi Asare-Addo
Kofi Asare-Addo
Ibuprofen exhibits poor flow, poor compaction and dissolution behaviour, and it is prone to capping after ejection from the die, therefore it needs particle modification.

5 July 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
RSRasool Soltani
Rasool Soltani
Mustafa GhanadianMustafa Ghanadian
Mustafa Ghanadian
BIBijan Iraj
Bijan Iraj
AHAlireza Homayouni
Alireza Homayouni
TETanin Shahmiveh Esfahani
Tanin Shahmiveh Esfahani
MAMojtaba Akbari
Mojtaba Akbari
Background. Berberis integerrima Bunge fruits have been utilized in traditional medicine to control diabetes mellitus (DM). However, no clinical survey has been done in this regard. This study was conducted to clinically evaluate the effects of fruit extract of this plant in improving glycemic control indices in patients with type 2 DM (T2DM). Methods. In a randomized controlled clinical trial, patients with T2DM who met the inclusion criteria were randomly divided into two groups of drug (Berberis) and control to receive the extract solution 5 ml twice daily (equivalent to 1000 mg of dry extract) with standard treatment (metformin) or only standard treatment, respectively, for 8 weeks. Before and after the intervention, fasting blood sugar (FBS), serum glycosylated hemoglobin (HbA1c), serum insulin, the homeostasis assessment model for insulin resistance (HOMA-IR), body mass index (BMI), and systolic and diastolic blood pressure were determined and compared between the two groups. Results. During the study, 30 and 35 patients in the drug and control groups, respectively, completed the study. Although no significant changes occurred in any parameter within each group, postintervention FBS (117.5 [107–128.8] versus 134 [120–142], ) and HbA1c (7 [6.4–7.7] versus 7.5 [6.8–7.9], ) were significantly lower in the drug group than in the control one. In terms of other parameters, there were no significant differences between the groups. Conclusion. Consumption of B. integerrima Bunge fruit extract at a dosage of 1000 mg daily decreases FBS and HbA1c but does not affect HOMA-IR in patients with type 2 diabetes mellitus.